The Africa in-vitro diagnostics market was valued at roughly $0.93 billion in 2023 and is projected to reach $1.45 billion by 2030 — a compound annual growth rate of around 6%. Point-of-care testing is named as one of the key drivers of that growth. Here's why that's not just an industry statistic.
The problem POC testing actually solves
Traditional lab-based diagnostics work well where there's a lab nearby, reliable transport for samples, and a wait of hours or days that patients and clinicians can absorb. Across large parts of the continent, one or more of those conditions doesn't hold. A sample that has to travel to a central lab adds delay, cost, and risk of degradation in transit — and for a fast-moving infection or an urgent cardiac marker, that delay can be the difference between a result that's useful and one that isn't.
Point-of-care testing moves the result to wherever the patient already is — a clinic, a pharmacy counter, a mobile outreach unit — and returns it in minutes rather than days. It doesn't replace laboratory medicine; it complements it, covering the cases where speed and access matter more than the extra precision a full lab workup provides.
What's actually driving the growth
- Expanding healthcare infrastructure investment across the continent, gradually improving access to both lab and point-of-care diagnostic capacity.
- Growing general awareness of disease detection and monitoring, which increases demand for testing of every kind — not just point-of-care.
- Point-of-care technology specifically filling gaps in emergency departments, ambulances, and remote settings where a lab result simply isn't fast enough to act on.
What this means if you're buying, not just reading about it
For clinics, pharmacies, and distributors, the practical takeaway is that point-of-care capacity is becoming a baseline expectation, not a nice-to-have. Buyers evaluating suppliers should be asking less "can you get me test kits" and more "can you get me test kits reliably, at the volumes I actually need, with the lead times my patients or customers require." That's the gap a growing, still-maturing market tends to expose — and it's exactly where sourcing and logistics experience starts to matter as much as the product itself.
Source: Meticulous Research, "Africa IVD Market Size, Share, Forecasts & Trends 2025–2032."